Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$8.93 -0.30 (-3.25%)
As of: Oct 2, 2026 · 1:50 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Accumulated Expenses (2010 - 2024)

Updated

Tonix Pharmaceuticals Holding's Accumulated Expenses came in at $33,000 for Q2 2024.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Accumulated Expenses (2010 - 2024) Analysis & Trends

At the end of FY2023, Tonix Pharmaceuticals Holding's Accumulated Expenses was $44,000.

  • Accumulated Expenses carries a five-year compound annual growth rate of -48.8% (FY2018 to FY2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tonix Pharmaceuticals Holding 163.56 Mn 163.56 Mn 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 33,000.00
Dec 31, 2023 44,000.00
Sep 30, 2023 32,000.00
Dec 31, 2018 1.25 Mn
Sep 30, 2018 1.30 Mn
Jun 30, 2018 872,000.00
Dec 31, 2017 830,000.00
Sep 30, 2017 475,000.00
Dec 31, 2016 1.24 Mn
Mar 31, 2016 1.84 Mn
Dec 31, 2015 3.60 Mn
Sep 30, 2015 2.68 Mn
Jun 30, 2015 1.85 Mn
Mar 31, 2015 1.53 Mn
Dec 31, 2014 1.90 Mn
Sep 30, 2014 1.05 Mn
Jun 30, 2014 573,000.00
Mar 31, 2014 596,000.00
Dec 31, 2013 1.17 Mn
Sep 30, 2013 853,859.00
API Access

Tonix Pharmaceuticals Holding Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TNXP&period=max&api_key=YOUR_API_KEY